• Home
  • Ambrisentan 5mg
  • Ambrisentan 5mg

Ambrisentan 5mg

52239

Ambrisentan is used to treat pulmonary arterial hypertension, a condition where high pressure in the blood vessels of the lungs makes the heart work harder and causes breathlessness.

It can help improve exercise ability and slow worsening of symptoms in people with this type of lung blood-pressure disease.

Usual dose range: 5mg to 10mg once daily, with 5mg once daily commonly used at the start and 10mg once daily used when a higher dose is needed and tolerated.

Indications vary by country and change over time; this website contains information for general patient information and should be checked against local prescribing information before clinical use.

Verification Approach: Each indication and usual dose-range sentence was drafted from at least two recognised medicines information sources, usually FDA/DailyMed or an FDA label plus EMA/eMC, MedlinePlus, Mayo Clinic, Cancer Research UK, NCI/ Cancer.gov, or another reputable medicines-information source. Doses are general adult/patient-information ranges and must not be used to prescribe or change treatment.
  • FDA/DailyMed prescribing information and FDA Oncology/Hematology approval notifications.
  • EMA and UK eMC Summary of Product
    Characteristics and patient leaflets where available.
  • NCI Cancer Drug Information/Cancer.gov and Cancer Research UK medicine information where available.
  • MedlinePlus, NHS/NICE, and other national medicines information for non-oncology or immune/respiratory medicines.
  • Peer-reviewed FDA approval summaries or manufacturer regulatory notices for very new, withdrawn, or region-specific
    indications.